Enhancing Engagement With Clinical Trial
Findings For A New Breast Cancer Drug
Project Summary:
Enago Life Sciences expertly managed the dissemination of critical phase 3 trial results for a new breast cancer drug. Using a variety of innovative and interactive communication tools, we ensured that the scientific community and the public received timely, accessible, and engaging information about the drug’s efficacy and safety.
Challenge:
The completion of the groundbreaking first phase 3 trial for a new breast cancer treatment required rapid and effective communication of the results to a global audience.
Approach:
The Enago Life Sciences team crafted a comprehensive communication strategy employing scientific writers, graphic designers, and a project manager.
The team produced interactive slide presentations, annotated PDF documents, abstract videos, and immediate publication alerts.
Each material was designed to maximize clarity and engagement, with meticulous attention to the coordination of global teams to ensure timely approvals and readiness for dissemination.
Impact :
The distribution was both timely and effective, leading to widespread recognition and understanding of the trial results. The medical professionals were equipped with the knowledge to discuss the new treatment options credibly, and public awareness of the drug’s potential increased significantly. This project not only established the drug’s potential but also reinforced Enago Life Sciences’ reputation for excellence in medical communication.